# Wesbanco Inc: overview

WSBC · Nasdaq · CIK 203596 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wsbc.md) · [Financials](/companies/wsbc/financials.md) · [Filings](/companies/wsbc/filings.md) · [Insiders](/companies/wsbc/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | not reported | [(0.15)](/filings/0001193125-26-197299.md) | [0.57](/filings/0001193125-26-326145.md) | [0.84](/filings/0001193125-26-437801.md) | not reported | [0.88](/filings/0001193125-26-197299.md) | [0.91](/filings/0001193125-26-326145.md) | [0.88](/filings/0001193125-26-437801.md) |
| Free cash flow | $m | [62.8 d](/filings/0001193125-26-085463.md) | [(30.7)](/filings/0001193125-26-197299.md) | [98.3 d](/filings/0001193125-26-326145.md) | [115 d](/filings/0001193125-26-437801.md) | [92.3 d](/filings/0001193125-26-085463.md) | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [3.53](/filings/0000950170-24-020323.md) | [3.02](/filings/0000950170-25-030795.md) | [2.51](/filings/0001193125-26-085463.md) | [2.26](/filings/0001193125-26-085463.md) | [2.23](/filings/0001193125-26-085463.md) |
| Free cash flow | $m | [328](/filings/0000950170-24-020323.md) | [196](/filings/0000950170-25-030795.md) | [147](/filings/0001193125-26-085463.md) | [201](/filings/0001193125-26-085463.md) | [280](/filings/0001193125-26-085463.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/wsbc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $364.0m | 9,325,960 |  | Added +1,705,323 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $227.5m | 5,828,359 |  | Added +1,056,072 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $220.6m | 5,616,212 |  | Added +1,845,027 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $219.2m | 5,616,959 |  | Added +165,615 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $168.7m | 4,323,071 |  | Added +1,900 |
| [NOMURA ASSET MANAGEMENT INTERNATIONAL INC.](/funds/921739.md) | 2026-06-30 | $156.5m | 4,009,892 |  | Added +159,836 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $112.3m | 2,877,905 |  | Added +767,741 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $100.5m | 2,575,264 |  | Added +148,060 |
| [Hood River Capital Management LLC](/funds/1578177.md) | 2026-06-30 | $92.4m | 2,367,331 |  | Added +353,378 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $84.6m | 2,166,582 |  | Added +469,732 |

## Recent filings

[All 2,092 filings](/companies/wsbc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:10 ET | [10-Q](/filings/0001193125-26-437801.md) | Quarterly report, period 2026-09-30 | 0001193125-26-437801 |
| 2026-10-21 | 16:21 ET | [8-K](/filings/0001193125-26-427870.md) | 9.01 Financial statements and exhibits | 0001193125-26-427870 |
| 2026-10-02 | 16:24 ET | [8-K](/filings/0001193125-26-412356.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-412356 |
| 2026-08-27 | 17:31 ET | [8-K](/filings/0001193125-26-371610.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-371610 |
| 2026-07-30 | 16:15 ET | [10-Q](/filings/0001193125-26-326145.md) | Quarterly report, period 2026-06-30 | 0001193125-26-326145 |
| 2026-07-21 | 16:24 ET | [8-K](/filings/0001193125-26-310361.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-310361 |
| 2026-07-02 | 16:26 ET | [8-K](/filings/0001193125-26-294653.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-294653 |
| 2026-06-04 | 16:31 ET | [8-K](/filings/0001193125-26-257536.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-257536 |
| 2026-05-20 | 16:23 ET | [8-K](/filings/0001193125-26-232649.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-232649 |
| 2026-05-04 | 16:35 ET | [8-K](/filings/0001193125-26-204123.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-204123 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-085463.md), filed Mar 2, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 203596
- Tickers: WSBC, WSBCO
- Exchange: Nasdaq
- SIC code: 6021 National Commercial Banks
- State of incorporation: WV
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 17:32 ET. No prices; not investment advice.
